Study points to simpler lab model for feline coronavirus research: full analysis

CURRENT FULL VERSION: A new Veterinary Record Open study suggests researchers may have found a more practical way to grow feline coronavirus from naturally occurring FIP cases in the lab. Investigators at Murdoch University successfully propagated virus from three clinically diagnosed feline infectious peritonitis cases in Vero cells, documenting cytopathic effects and confirming viral replication with RT-qPCR and sequencing. If the findings hold up, they could help address one of the long-running bottlenecks in FIP research: getting clinically relevant virus to grow reliably in accessible cell culture systems. (pmc.ncbi.nlm.nih.gov)

That bottleneck has been a real one. The paper notes that feline coronavirus, particularly type I strains, is generally difficult to propagate in vitro, often requiring feline macrophage-derived cultures and still replicating poorly. Earlier work has highlighted the same challenge, including studies showing how limited susceptible cell lines have constrained research on feline coronavirus biology. In that context, a non-feline, broadly available cell line such as Vero could be useful simply because more labs can work with it. (pmc.ncbi.nlm.nih.gov)

The Murdoch team studied three male cats, ages 6 to 12 months, identified between July and September 2024 in Perth, Western Australia. Peritoneal effusion samples tested positive for feline coronavirus by RT-qPCR targeting the 7b gene, and amplicon sequencing showed high similarity to reference feline coronavirus sequences without cross-reactivity to SARS-CoV-2 or other coronaviruses. After inoculation into Vero cells, mild cytopathic effects appeared by day 5 in first passage, then earlier in second passage, with progressively decreasing Ct values supporting ongoing replication. Phylogenetic analysis placed the three sequences in the same clade, though with some nucleotide variation between cases. (pmc.ncbi.nlm.nih.gov)

The authors argue that this could open the door to more routine virus isolation, fuller genome sequencing, host-virus interaction studies, antiviral resistance work, and preliminary vaccine research. They also make an important inference about the isolates themselves: because the virus adapted to Vero cells, the strains may be genotype 2, which is generally considered more permissive in non-feline cell lines. But they stop short of claiming that definitively, noting that serologic testing and additional characterization are still needed. They also acknowledge that co-infections were not ruled out with multiplex PCR, and they plan metagenomic analysis or broader testing in future work. (pmc.ncbi.nlm.nih.gov)

There wasn’t much direct outside commentary on this specific paper in the public record, but the broader field helps explain why the result is getting attention. Recent UC Davis reporting on naturally occurring FIP described evidence that the virus infects a broader range of immune cells than previously thought, including B and T lymphocytes in lymph nodes, and that it may actively replicate in those cells rather than simply leaving behind residual viral material. The same work also raised the possibility that viral traces can persist in immune cells even after antiviral treatment and apparent clinical recovery, making cats with FIP a potentially useful real-world model for longer-term coronavirus disease biology and post-viral inflammatory syndromes. That work points to a bigger trend: FIP research is increasingly being viewed not just as feline infectious disease work, but as a platform for studying coronavirus persistence, immune dysfunction, and therapeutic response. (ucdavis.edu)

Why it matters: For veterinary professionals, the immediate takeaway isn’t a new diagnostic or treatment protocol. It’s that the lab toolkit around FIP may be improving at a time when clinical interest in the disease is rising. Updated ABCD guidance from 2025 reflects a fast-moving landscape that now includes antiviral treatment experience, ongoing questions about immunity, and concern about unusual epidemiology such as the Cyprus FCoV-23 outbreak, where investigators reported a sharp rise in cases and suspected cat-to-cat transmission of a highly virulent recombinant strain. ISFM guidance adds practical context: the Cyprus outbreak spread quickly enough to affect indoor cats, has prompted concern about international movement of cats, and has reinforced recommendations around hygiene, litter tray sanitation, avoiding large-group housing, and minimizing travel or rehoming from affected areas without testing. Legal antiviral options including remdesivir and GS-44152 are now available there, but cost remains a limiting factor. Better culture systems could help researchers compare field strains, study antiviral susceptibility, and respond more quickly when outbreak-linked variants emerge. (abcdcatsvets.org)

There are still reasons for caution. Vero cells are useful because they’re permissive and produce clear cytopathic effects, but that same convenience can come with tradeoffs. The study itself notes that Vero cells lack feline-specific immune features and may be poorly suited for pathogenesis questions. That limitation matters even more as evidence accumulates that FIP-associated coronavirus may target multiple immune cell populations in vivo. More broadly, virology literature from other coronaviruses has shown that serial passage in Vero cells can select for adaptations that do not fully reflect what is circulating in the natural host, so any downstream drug, vaccine, or virulence conclusions will need careful validation in feline-relevant systems. That’s an inference from broader virology practice, not a finding of this study, but it’s a familiar issue for translational lab models. (pmc.ncbi.nlm.nih.gov)

What to watch: The next steps are likely to be larger validation studies, deeper genomic characterization of propagated isolates, and proof-of-concept work showing whether this Vero-cell platform can actually support antiviral screening, resistance testing, or vaccine antigen production in a way that translates back to feline patients and veterinary practice. It will also be worth watching whether investigators can use more standardized culture methods to study immune-cell tropism, persistence after treatment, and high-concern outbreak strains such as those linked to Cyprus. (pmc.ncbi.nlm.nih.gov)